Results 141 to 150 of about 90,287 (254)

Editorial: Microbiome in an immunocompromised host- a jungle of challenges or a glacier of hidden opportunities? [PDF]

Front Cell Infect Microbiol
Wojciuk B, Falcone EL, Lawson R.
europepmc   +1 more source

Sepsis in Immunocompromised Hosts

Journal of the Royal College of Physicians of London, 2000
openaire   +2 more sources

Challenges of Dengue in Hematological Disease Patients: Descriptive Analysis From the DANGO Registry During the 2023–2024 Outbreak in Argentina

Transplant Infectious Disease, EarlyView.
During the 2023–2024 Argentine dengue outbreak, 33 patients with hematological disease showed high complication rates, frequent hospitalization (64%), severe thrombocytopenia (90%), and 6% dengue‐attributable mortality. Transfusion‐associated cases were documented.
Gustavo Adolfo Méndez, Carla Niveyro, Pedro Andrés Villalba Apestegui, Victoria Isabel Martin, Lucila María Compañy Kec, María Cynthia Tomasino, Mariana del Carmen del Marull, Haydee Ingrid Bernard, Claudia Patricia Lorena Fernández, Flavia Marcela Pelech, Maria Fernanda Tosin, María Fernanda González‐Hobecker, Karen Beatrice Duranona, Angela Daiana Jara, Justus Cornely, Oliver A. Cornely, Jon Salmanton‐García   +16 more
wiley   +1 more source

Double Trouble: Leishmaniasis and Cytomegalovirus Colitis in an Immunocompromised Host. [PDF]

ACG Case Rep J
Alghaythi S, Almuhaidb A, Al-Bawardy B.
europepmc   +1 more source

Delayed organising pneumonia in an immunocompromised host after a mild COVID-19 infection. [PDF]

BMJ Case Rep, 2023
Tiew HW, Tan JWP, Teo CHY.
europepmc   +1 more source

Lung Biopsies in Patients Referred for Allogeneic Hematopoietic Cell Transplantation: Diagnostic Accuracy, Diagnostic Yield, and Clinical Utility

Transplant Infectious Disease, EarlyView.
Among patients referred for allogeneic hematopoietic cell transplantation with pulmonary opacities, lung biopsy provided a diagnosis in 72% of procedures and altered management in 51%. Despite a 7% major complication rate, lung biopsy frequently clarified noninfectious etiologies when bronchoscopy was inconclusive.
Sergio Rodriguez‐Rodriguez, Ayman Sayyed, Swe Mar Linn, Caden Chiarello, Mats Remberger, Igor Novitzky‐Basso, Patrik Rogalla, Shahid Husain, Jonas Mattsson   +8 more
wiley   +1 more source

Chronic and reactivated dengue infection in an immunocompromised host: insights from a case report. [PDF]

Trop Med Health
Di Ascia L, Frumence E, Traversier N, Saint-Pastou C, Grard G, Vacher-Coponat H, de Lamballerie X, Jaffar-Bandjee MC.   +7 more
europepmc   +1 more source

Dual Antiviral Therapy for Persistent Coronavirus Disease 2019 and Associated Organizing Pneumonia in an Immunocompromised Host. [PDF]

Clin Infect Dis, 2023
Trottier CA, Wong B, Kohli R, Boomsma C, Magro F, Kher S, Anderlind C, Golan Y.   +7 more
europepmc   +1 more source

Vaccination of immunocompromised hosts

, 2013
openaire   +1 more source

The Troll Is Weakened but Not yet Defeated: An Update on Cytomegalovirus Management in Transplantation From the International CMV Symposium 2025

Transplant Infectious Disease, EarlyView.
This review synthesizes discussions from the 2025 International CMV Symposium on translating three recently updated international guidelines into clinical practice across solid organ and hematopoietic stem cell transplantation, highlighting advances in risk‐stratified prevention, emerging therapies, immune monitoring, and persistent implementation ...
Camille N. Kotton, Martina Sester, Julian Torre‐Cisneros, The International CMV Symposium Faculty   +3 more
wiley   +1 more source